{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:03:11Z","timestamp":1777460591038,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100008736","name":"Fondef","doi-asserted-by":"crossref","award":["D09I1262"],"award-info":[{"award-number":["D09I1262"]}],"id":[{"id":"10.13039\/501100008736","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.bbagen.2015.04.012","type":"journal-article","created":{"date-parts":[[2015,5,7]],"date-time":"2015-05-07T06:03:37Z","timestamp":1430978617000},"page":"1685-1693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Post-translational modification of a chimeric EPO-Fc hormone is more important than its molecular size in defining its in vivo hematopoietic activity"],"prefix":"10.1016","volume":"1850","author":[{"given":"Emilio R.","family":"Salgado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Montesino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sivana P.","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Hugues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar I.","family":"Cabezas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Maura-Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulina","family":"Saavedra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Lamazares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Salas-Burgos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan C.","family":"Vera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliberto","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9879-7710","authenticated-orcid":false,"given":"Jorge R.","family":"Toledo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2015.04.012_bb0260","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev.me.29.020178.000411","article-title":"Erythropoietin and the control of red cell production","volume":"29","author":"Graber","year":"1978","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0265","doi-asserted-by":"crossref","first-page":"44","DOI":"10.7326\/0003-4819-94-1-44","article-title":"Erythropoietin radioimmunoassay in evaluating patients with polycythemia","volume":"94","author":"Koeffler","year":"1981","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0270","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nbt0188-67","article-title":"Production of recombinant human erythropoietin in mammalian cells: host\u2013cell dependency of the biological activity of the cloned glycoprotein","volume":"6","author":"Goto","year":"1988","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0010","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.biotechadv.2011.08.022","article-title":"Mammalian cell protein expression for biopharmaceutical production","volume":"30","author":"Zhu","year":"2012","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-3089.2011.00622.x","article-title":"Potential impact of the non-human sialic acid N-glycolylneuraminic acid on transplant rejection risk","volume":"18","author":"Padler-Karavani","year":"2011","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.bbagen.2015.04.012_bb0020","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ymben.2010.08.004","article-title":"A functional analysis of N-glycosylation-related genes on sialylation of recombinant erythropoietin in six commonly used mammalian cell lines","volume":"12","author":"Zhang","year":"2010","journal-title":"Metab. Eng."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0025","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.copbio.2006.06.010","article-title":"Challenges in therapeutic glycoprotein production","volume":"17","author":"Sethuraman","year":"2006","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0030","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1023\/A:1008882332133","article-title":"Expression of human erythropoietin transgenes and of the endogenous WAP gene in the mammary gland of transgenic rabbits during gestation and lactation","volume":"7","author":"Aguirre","year":"1998","journal-title":"Transgenic Res."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0035","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1432-1033.1997.00482.x","article-title":"Expression of bovine beta-lactoglobulin\/human erythropoietin fusion protein in the milk of transgenic mice and rabbits","volume":"245","author":"Korhonen","year":"1997","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0040","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1051\/rnd:19960511","article-title":"The deleterious effects of human erythropoietin gene driven by the rabbit whey acidic protein gene promoter in transgenic rabbits","volume":"36","author":"Massoud","year":"1996","journal-title":"Reprod. Nutr. Dev."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0045","first-page":"187","article-title":"Expression of human erythropoietin gene in the mammary gland of a transgenic mouse","volume":"47","author":"Mikus","year":"2001","journal-title":"Folia Biol. (Praha)"},{"key":"10.1016\/j.bbagen.2015.04.012_bb0050","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jbiotec.2004.06.009","article-title":"Adenoviral vector mediates high expression levels of human growth hormone in the milk of mice and goats","volume":"114","author":"Sanchez","year":"2004","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0055","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jbiotec.2005.10.019","article-title":"High expression level of recombinant human erythropoietin in the milk of non-transgenic goats","volume":"123","author":"Toledo","year":"2006","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0065","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.abb.2010.05.006","article-title":"The N-glycosylation of classical swine fever virus E2 glycoprotein extracellular domain expressed in the milk of goat","volume":"500","author":"Montesino","year":"2010","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0070","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jmb.2011.07.061","article-title":"The effect of glycosylation on the folding kinetics of erythropoietin","volume":"412","author":"Banks","year":"2011","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0075","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood.V77.3.419.419","article-title":"Erythropoietin","volume":"77","author":"Krantz","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.bbagen.2015.04.012_bb0080","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0301-472X(03)00006-7","article-title":"Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin","volume":"31","author":"Egrie","year":"2003","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0085","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1182\/blood.V73.1.84.84","article-title":"Survival of recombinant erythropoietin in the circulation: the role of carbohydrates","volume":"73","author":"Fukuda","year":"1989","journal-title":"Blood"},{"issue":"Suppl. 3","key":"10.1016\/j.bbagen.2015.04.012_bb0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ndt\/16.suppl_3.3","article-title":"Development and characterization of novel erythropoiesis stimulating protein (NESP)","volume":"16","author":"Egrie","year":"2001","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0095","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.exphem.2004.08.004","article-title":"Control of rHuEPO biological activity: the role of carbohydrate","volume":"32","author":"Elliott","year":"2004","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0100","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/nbt799","article-title":"Enhancement of therapeutic protein in vivo activities through glycoengineering","volume":"21","author":"Elliott","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0105","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/08830189309061697","article-title":"Immunoadhesins","volume":"10","author":"Ashkenazi","year":"1993","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0110","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/jps.2600830621","article-title":"Intratracheal delivery of peptide and protein agents: absorption from solution and dry powder by rat lung","volume":"83","author":"Komada","year":"1994","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0115","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jconrel.2010.04.021","article-title":"PEGylation markedly enhances the in vivo potency of recombinant human non-glycosylated erythropoietin: a comparison with glycosylated erythropoietin","volume":"145","author":"Wang","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbagen.2015.04.012_bb0120","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1182\/blood.V97.12.3776","article-title":"Dimeric erythropoietin fusion protein with enhanced erythropoietic activity in vitro and in vivo","volume":"97","author":"Dalle","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbagen.2015.04.012_bb0125","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1126\/science.1079085","article-title":"Design and chemical synthesis of a homogeneous polymer-modified erythropoiesis protein","volume":"299","author":"Kochendoerfer","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2015.04.012_bb0130","doi-asserted-by":"crossref","first-page":"e72673","DOI":"10.1371\/journal.pone.0072673","article-title":"Pharmacokinetics and pharmacodynamics of recombinant human EPO-Fc fusion protein in vivo","volume":"8","author":"Shi","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbagen.2015.04.012_bb0135","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/protein\/gzi021","article-title":"Improvement of Fc-erythropoietin structure and pharmacokinetics by modification at a disulfide bond","volume":"18","author":"Way","year":"2005","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0140","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1073\/pnas.95.5.2509","article-title":"A simplified system for generating recombinant adenoviruses","volume":"95","author":"He","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10495390009525943","article-title":"Hormonal induced lactation in transgenic goats","volume":"11","author":"Cammuso","year":"2000","journal-title":"Anim. Biotechnol."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0150","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jbiotec.2007.09.014","article-title":"Highly protective E2-CSFV vaccine candidate produced in the mammary gland of adenoviral transduced goats","volume":"133","author":"Toledo","year":"2008","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0155","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2015.04.012_bb0160","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/abio.1995.1468","article-title":"Nonselective and efficient fluorescent labeling of glycans using 2-amino benzamide and anthranilic acid","volume":"230","author":"Bigge","year":"1995","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0165","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/abio.1994.1478","article-title":"Analytical and preparative separation of anionic oligosaccharides by weak anion-exchange high-performance liquid chromatography on an inert polymer column","volume":"222","author":"Guile","year":"1994","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0170","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1006\/abio.1996.0351","article-title":"A rapid high-resolution high-performance liquid chromatographic method for separating glycan mixtures and analyzing oligosaccharide profiles","volume":"240","author":"Guile","year":"1996","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0175","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0076-6879(03)74020-8","article-title":"Modeller: generation and refinement of homology-based protein structure models","volume":"374","author":"Fiser","year":"2003","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0180","doi-asserted-by":"crossref","first-page":"W214","DOI":"10.1093\/nar\/gki385","article-title":"GlyProt: in silico glycosylation of proteins","volume":"33","author":"Bohne-Lang","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0185","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1128\/JVI.72.3.2022-2032.1998","article-title":"In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1\/E2A, or E1\/E4 deleted","volume":"72","author":"Lusky","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0190","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1073\/pnas.91.10.4407","article-title":"Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy","volume":"91","author":"Yang","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0195","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.1182\/blood.V91.12.4561","article-title":"Transgenically produced human antithrombin: structural and functional comparison to human plasma-derived antithrombin","volume":"91","author":"Edmunds","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbagen.2015.04.012_bb0200","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jbiotec.2005.01.001","article-title":"Effect of genetic background on glycosylation heterogeneity in human antithrombin produced in the mammary gland of transgenic goats","volume":"117","author":"Zhou","year":"2005","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0205","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.abb.2007.11.019","article-title":"Monosialylated biantennary N-glycoforms containing GalNAc-GlcNAc antennae predominate when human EPO is expressed in goat milk","volume":"470","author":"Montesino","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0210","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1021\/mp100353a","article-title":"Erythropoietin produced in a human cell line (Dynepo) has significant differences in glycosylation compared with erythropoietins produced in CHO cell lines","volume":"8","author":"Shahrokh","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0215","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1021\/pr800725v","article-title":"N-glycosylation pattern of E2 glycoprotein from classical swine fever virus","volume":"8","author":"Montesino","year":"2009","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0220","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jbiotec.2011.11.002","article-title":"Optimization of erythropoietin production with controlled glycosylation-PEGylated erythropoietin produced in glycoengineered Pichia pastoris","volume":"157","author":"Nett","year":"2012","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0225","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1365-2141.2003.04307.x","article-title":"Relationships between the N-glycan structures and biological activities of recombinant human erythropoietins produced using different culture conditions and purification procedures","volume":"121","author":"Yuen","year":"2003","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0230","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1053\/ajkd.2001.29264","article-title":"Novel erythropoiesis stimulating protein for managing the anemia of chronic kidney disease","volume":"38","author":"Nissenson","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0235","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0167-7799(03)00190-2","article-title":"Making recombinant proteins in animals\u2014different systems, different applications","volume":"21","author":"Dyck","year":"2003","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0240","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.copbio.2009.10.008","article-title":"Expression systems for therapeutic glycoprotein production","volume":"20","author":"Durocher","year":"2009","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0245","article-title":"Expression systems and species used for transgenic animal bioreactors","author":"Wang","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bbagen.2015.04.012_bb0250","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1182\/blood.V77.12.2624.2624","article-title":"The importance of N- and O-linked oligosaccharides for the biosynthesis and in vitro and in vivo biologic activities of erythropoietin","volume":"77","author":"Wasley","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.bbagen.2015.04.012_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1000918","article-title":"An introduction to biomolecular graphics","volume":"6","author":"Mura","year":"2010","journal-title":"PLoS Comput. Biol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416515001178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416515001178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T22:24:55Z","timestamp":1598999095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416515001178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0304416515001178"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2015.04.012","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-translational modification of a chimeric EPO-Fc hormone is more important than its molecular size in defining its in vivo hematopoietic activity","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2015.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}